|
|
| Catalog Number |
EX500 |
| Medical Device Problem Code |
Defective Component (2292)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
08/29/2026
|
|
Type of Reportable Event
|
Malfunction
|
|
Event or Problem Description
|
|
As reported, the indicator window of a 5f exoseal vascular closure device (vcd) could not change to black-black, so the device was withdrawn directly from the body.Hemostasis was achieved with manual compression.There was no reported patient injury.The operator used the device to close the puncture site.There were no visible signs of device or package damage prior to use.The device was stored and prepared according to the instructions for use (ifu).There was no difficulty connecting the vascular sheath introducer with the exoseal vcd.The indicator wire cowling locked against the handle assembly, and an audible click was heard.Pulsatile flow was observed from the bleed-back indicator.The exoseal vcd and vascular sheath introducer were retracted together until bleed-back significantly slowed or stopped.The physician did not have their thumb on the plug deployment button during retraction.The indicator window did not show red during retraction.When the device was removed from the patient, the indicator wire loop was deployed/showing, and no anomalies were noted to the loop.Outside the patient's body, the guidewire loop required considerable force to make the indicator window turn black-black.A non-cordis catheter sheath introducer was used.Angiography confirmed suitability of the femoral artery, including the vascular sheath introducer insertion angle.The vessel diameter was confirmed to be greater than or equal to 5 mm.There was no visible calcium/plaque at the puncture site and no access vessel tortuosity.There was no stent near the puncture site, and there was no vessel stenosis greater than 50% at or near the puncture site.The target femoral site had not been previously closed with a closure device or manual compression within 30 days before the procedure.There was no evidence of pre-existing hematoma, arteriovenous fistula, or pseudoaneurysm at the access site prior to exoseal vcd use.The exoseal vcd was used in a diagnostic procedure with a retrograde approach.The patient's body mass index (bmi) was not greater than 40.The physician had achieved certification for use of the exoseal vcd.The device will be returned for evaluation.
|
| |
|
Additional Manufacturer Narrative
|
|
Due to system limitations, section h6 required to input type of investigation, investigation findings, and investigation conclusions for an initial report.Pending additional information to complete investigation.This device is available for analysis, but the engineering report is not yet available.However, it will be submitted within 30 days upon receipt.Additional information is pending and will be submitted within 30 days upon receipt.
|
| |
|
Search Alerts/Recalls
|
|
|